Recent Publications and Grants

Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.

Recent Publications

Research Grants

  • A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration. John Sullivan (Principal Investigator). VA Central Office. $330,000. 1/1/2025-12/1/2027.
  • Modulation of oligodendrocyte development by voltage-operated calcium channels. Pablo Paez (Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,993,750. 12/1/2021-11/1/2027.
  • Center for Advanced Technology in Big Data and Health Sciences. Norma Nowak (Principal Investigator). New York State Department of Empire State Development. $9,200,000. 7/1/2017-6/1/2027.
  • Molecular mechanisms of skin immunity to Staphylococcal infection. Lee Ann Garrett-Sinha (Co-Principal Investigator). NIH. $527,503. 7/1/2022-6/1/2027.
  • A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis, BEAT-MS (Protocol ITN077AI). Bianca Weinstock-Guttman (Principal Investigator). National Institute of Allergy & Infectious Diseases (NIAID), Division of Allergy, Immunology &Transplantation (DAIT) via a subaward. 1/1/2020-12/1/2026.
  • MARCH proteins, members of a host protein family that targets HIV. Spyridon Stavrou (Principal Investigator). NIH/NIAID. $1,974,920. 12/1/2021-11/1/2026.
  • Effects of mesolimbic amylin signaling on macronutrient intake. Jinwoo Park (Co-Investigator). NIH/NIDDK. $2,202,189. 12/1/2021-11/1/2026.
  • Tonawanda Coke Environmental Health Study. Laurene Tumiel Berhalter (Co-Investigator). US District Court for the Western District of New York. $11,100. 9/1/2016-9/1/2026.
  • A brief, transdiagnostic cognitive behavioral treatment for urologic chronic pelvic pain syndrome (UCPPS): Process, predictions, outcomes. Tova Ablove (Co-Investigator), Teresa Danforth (Co-Investigator), Gregory Gudleski (Co-Investigator), Jeffrey Lackner (Principal Investigator), Brian Quigley (Co-Investigator), Christopher Radziwon (Co-Investigator), Alison Vargovich (Co-Investigator). NIH NIDDK. $3,288,753. 9/1/2021-7/1/2026.
  • Ribosome Heterogeneity in C. neoformans. John Panepinto (Principal Investigator). NIAID / NIH. 8/1/2021-7/1/2026.
  • VA Merit Review, 2IO1BX002659, Preventing and Reversing Interstitial Fibrosis in HFpEF. John Canty, Jr. (Principal Investigator). Department of Veterans Affairs. $709,984. 7/1/2020-6/1/2026.
  • Administrative Supplements: Clinical, Genetic, and Cellular Consequences of Mutations in Na, K-ATP1A3. Allison Brashear (Principal Investigator). NINDS. $8,808,829. 4/1/2008-6/1/2026.
  • Energizing and protecting axons through metabolic coupling to Schwann cells. Bogdan Beirowski (Co-Investigator). NIH, NINDS. $376,139. 8/1/2021-6/1/2026.
  • The role of neutrophils in the age-driven decline in anti-pneumococcal vaccine responses. Elsa Bou Ghanem (Principal Investigator). NIA-R01. $1,575,931. 9/1/2021-5/1/2026.
  • Optimizing Chest Compressions for Bradycardia during Neonatal Resuscitation. Praveen Chandrasekharan (Principal Investigator). R01 - Eunice Kennedy Shriver National Institute of Child Health & Human Development. $1,500,000. 5/1/2021-4/1/2026.